ASSESSMENT OF RISK FACTORS FOR ARTERIAL HYPERTENSION HYPERTENSION IN PREGNANT WOMEN

  • Khusainova Munira Alisherovna Samarkand State Medical Institute, Samarkand, Uzbekistan
  • Yarmatov Suvon Tatlibayevich Samarkand State Medical Institute, Samarkand, Uzbekistan
Keywords: arterial hypertension, pregnant women, progressive placental insufficiency, fetal hypoxia, body mass index

Abstract

To date, arterial hypertension (AH) occupies a leading position among all extragenital diseases in pregnant women. In Russia, the frequency of occurrence of this pathology according to various data is from 4 to 30%, in Europe this indicator is 4-15%, and according to the World Health Organization – up to 20%. Despite the urgency, this problem is far from being solved, since hypertension of pregnant women occupies a special ("intermediate") position between two such different disciplines-obstetrics and therapy. In this respect, it is a typical example of a borderline problem, which has important theoretical and practical significance. The lack of full-fledged standards for the diagnosis and treatment of pregnant women with hypertension not only causes high maternal mortality, but also increases the number of adverse perinatal outcomes. Against the background of increased arterial pressure, pregnant women are significantly more likely to experience such dangerous complications as: progressive placental insufficiency, fetal hypoxia, and in severe cases, asphyxia and death of the child. Therefore, at the present stage, it is necessary to be able to predict and prevent the development of the disease in time. But at the moment, there are many inconsistent positions in the approaches to the examination, follow-up, and treatment of pregnant women with hypertension, which requires additional research in this area.

References

1. Daily monitoring of arterial pressure: methodological issues., A. N. Rogoza [et al.]; edited by G. G. Arabidze, O. Yu. Atkova. M., 1997; P 37.
2. Agarwal R. Systolic hypertension in hemodialysis patients. Semin. Dial. 2003; Vol.16., P 208-231
3. M.F. Canesin., et al., Ambulatory blood pressure monitoring of patients with heart failure. A new prognosis marker; Arq. Bras. Cardiol. 2002; Vol. 78(1). P 83-89.
4. C.K. Farmer., et al. An investigation of the effect of advancing ureamia, renal replacement therapy and renal transplantation on blood pressure diurnal variability; Nephrol. Dial. Transplant. 1997; №12; P 2301-2307.
5. J. Shin., et al. Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure; J. Card. Fail. 2007; Vol.13(8). P 656-662.
6. M.B. Davidson. et al., Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate; Arch. Intern. Med. 2006; Vol. 166. P 846-852.
7. S. Hoshide. et al., Associations between non-dipper of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives; Am. J. Hypertens. 2003. Vol. 16(6). P 434-438.
8. J. Ishikawa, et al., Cardiovascular risks of dipping status and chronic kidney disease in elderly Japanese hypertensive patients; J.Clin. Hypertens. 2008. Vol. 10(10). P 787-794.
9. M. Kanbay, et al., Causes and mechanisms of nondippering hypertension; Clin. Exp. Hypertens. 2008; Vol. 30(7). P 585-597.
10. N. Goto, et al., Circadian blood pressure rhythm is disturbed by nephrectomy; Hypertens. Res. 2005; Vol. 28(4). P 301-306.
11. E. Ingelson, et al., Diurnal blood pressure pattern and risk of congestive heart failure; JAMA. 2006. Vol. 295 (24). P 2859-2866.
12. A.S. Go, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcome and Resource Utilization (ANCHOR) Study; Circulation. 2006. Vol. 113(23). P 2713-2723.
13. Khusainova M., Nazarov F. FEATURES OF THE CIRCADIAN RHYTHM BLOOD PRESSURE IN PATIENTS HEART FAILURE AND IMPAIRED RENAL FUNCTION //InterConf. – 2021.
14. Tairov D. R., Yarmukhamedova S. K., Khusainova M. A. Characteristics of Metabolic Syndrome and Cardiovascular Injuries in Gout.
15. Alisherovna M. K. 24-Hour Abp Monitoring Of Blood Pressure In Patients With Chronic Heart Failure And The State Of Kidney Function //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2021. – Т. 2. – №. 1. – С. 197-204.
16. E.L. Knight, et al. Predictors of decreased renal function with heart failure during converting enzyme inhibitor therapy: results from studies of left ventricular dysfunction. Am. Heart J. 1999. №138. P 849-855.
17. A.de la Sierra,et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009. Vol. 53(3). P 466-472
18. K. Dimopoulos, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008. Vol. 117(18). P 2320-2328.
19. L.M. Prisant. Blunted nocturnal decline in blood pressure. J. Clin. Hypertens (Greenwich). 2004. Vol. 6(10). P 594-597.
Published
2021-06-12
How to Cite
Alisherovna , K. M., & Tatlibayevich, Y. S. (2021). ASSESSMENT OF RISK FACTORS FOR ARTERIAL HYPERTENSION HYPERTENSION IN PREGNANT WOMEN. Central Asian Journal of Medical and Natural Science, 2(3), 214-217. https://doi.org/10.17605/cajmns.v2i3.203
Section
Articles

Most read articles by the same author(s)